WHITE PETROLATUM JELLY

WHITE PETROLATUM JELLY was reported 104 times

WHITE PETROLATUM JELLY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SENSORY PROCESSING SENSITIVITY 1 0.0227
1 BULLOUS IMPETIGO 1 0.0167
2 PLATELET AGGREGATION ABNORMAL 1 0.0066
3 ADRENAL SUPPRESSION 5 0.0059
4 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
5 OCULAR ROSACEA 1 0.0049
6 GINGIVAL OPERATION 1 0.0045
7 ADENOIDAL DISORDER 1 0.0038
8 SHOPLIFTING 1 0.0036
9 PERIORBITAL IRRITATION 1 0.0029
10 TRIGEMINAL NERVE DISORDER 1 0.0029
11 EAR OPERATION 1 0.0027
12 APPLICATION SITE LACERATION 1 0.0024
13 INSULIN RESISTANCE 5 0.0024
14 FAECAL VOMITING 1 0.0019
15 PNEUMOCOCCAL SEPSIS 1 0.0015
16 THEFT 1 0.0015
17 INFLAMMATORY PAIN 1 0.0015
18 GASTROINTESTINAL SURGERY 1 0.0013
19 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
20 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
21 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
22 BRONCHIAL SECRETION RETENTION 1 0.0008
23 APPLICATION SITE EROSION 1 0.0008
24 SUDDEN ONSET OF SLEEP 1 0.0007
25 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
26 MEAN CELL VOLUME DECREASED 1 0.0006
27 TRANSCRIPTION MEDICATION ERROR 1 0.0006
28 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
29 SKULL FRACTURE 1 0.0006
30 RESPIRATORY ALKALOSIS 1 0.0006
31 TONSILLAR HYPERTROPHY 1 0.0006
32 EROSIVE OESOPHAGITIS 1 0.0006
33 FIXED ERUPTION 1 0.0006
34 PUPIL FIXED 1 0.0006
35 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
36 DIFFUSE ALOPECIA 1 0.0005
37 INFECTED SKIN ULCER 1 0.0005
38 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
39 SELF-MEDICATION 2 0.0005
40 COMPULSIVE SHOPPING 1 0.0005
41 IMPULSE-CONTROL DISORDER 1 0.0005
42 HORDEOLUM 2 0.0005
43 SKIN TIGHTNESS 2 0.0004
44 EYELID IRRITATION 1 0.0004
45 SYSTEMIC CANDIDA 1 0.0004
46 RETINAL DISORDER 1 0.0004
47 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
48 GAMBLING DISORDER 1 0.0004
49 APPLICATION SITE HAEMORRHAGE 1 0.0004
50 IMMUNE-MEDIATED MYOSITIS 1 0.0004
51 VITREOUS HAEMORRHAGE 1 0.0004
52 SKIN HYPERTROPHY 1 0.0004
53 HAEMATOLOGICAL MALIGNANCY 1 0.0004
54 ADENOVIRUS INFECTION 1 0.0003
55 MULTIPLE-DRUG RESISTANCE 1 0.0003
56 SKIN WEEPING 1 0.0003
57 FACIAL BONES FRACTURE 1 0.0003
58 RHINOVIRUS INFECTION 1 0.0003
59 SKIN FISSURES 5 0.0003
60 BLEPHARITIS 1 0.0002
61 APPLICATION SITE DISCOLOURATION 1 0.0002
62 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
63 HEPATOTOXICITY 5 0.0002
64 VASCULAR DEVICE INFECTION 1 0.0002
65 ROSACEA 1 0.0002
66 EYE INFLAMMATION 2 0.0002
67 ENTEROCOCCAL INFECTION 1 0.0002
68 STAPHYLOCOCCAL SEPSIS 1 0.0002
69 ANAL FISSURE 1 0.0002
70 STREPTOCOCCAL INFECTION 1 0.0002
71 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
72 MOUTH SWELLING 1 0.0002
73 INJECTION SITE VESICLES 1 0.0002
74 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
75 NASAL DRYNESS 1 0.0002
76 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
77 LARGE INTESTINE PERFORATION 1 0.0001
78 VISUAL FIELD DEFECT 1 0.0001
79 DERMATITIS BULLOUS 1 0.0001
80 MAJOR DEPRESSION 1 0.0001
81 APPLICATION SITE PAIN 3 0.0001
82 ARTHROPOD BITE 1 0.0001
83 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
84 GINGIVAL PAIN 1 0.0001
85 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
86 ESCHERICHIA INFECTION 1 0.0001
87 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
88 DRY SKIN 16 0.0001
89 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
90 ECZEMA 6 0.0001
91 DERMATITIS ATOPIC 6 0.0001
92 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
93 SKIN EXFOLIATION 9 0.0001
94 LIGAMENT SPRAIN 1 0.0001
95 TENDERNESS 1 0.0001
96 INJECTION SITE DISCOMFORT 1 0.0001
97 SCRATCH 1 0.0001
98 PHARYNGITIS STREPTOCOCCAL 1 0.0001
99 MALNUTRITION 1 0.0001
100 SKIN INFECTION 1 0.0001
101 OCULAR DISCOMFORT 1 0.0001
102 REBOUND EFFECT 1 0.0001
103 ELECTROLYTE IMBALANCE 1 0.0001
104 ADRENAL INSUFFICIENCY 1 0.0001
105 HAIR COLOUR CHANGES 1 0.0001
106 DERMATITIS ALLERGIC 1 0.0001
107 HEPATIC CYTOLYSIS 1 0.0001
108 IMMUNE SYSTEM DISORDER 1 0.0001
109 EAR INFECTION 2 0.0001
110 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
111 APHONIA 1 0.0001
112 BLINDNESS UNILATERAL 1 0.0001
113 SKIN HAEMORRHAGE 1 0.0001
114 ECONOMIC PROBLEM 1 0.0001
115 THERAPEUTIC RESPONSE DECREASED 4 0.0001
116 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
117 DRUG DISPENSING ERROR 1 0.0001
118 HIP ARTHROPLASTY 1 0.0001
119 MUSCULOSKELETAL CHEST PAIN 1 0.0001
120 TENDONITIS 1 0.0001
121 THERAPY PARTIAL RESPONDER 1 0.0001
122 BASAL CELL CARCINOMA 1 0.0001
123 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
124 METABOLIC ACIDOSIS 2 0.0001
125 PHOTOSENSITIVITY REACTION 1 0.0001
126 CANDIDA INFECTION 1 0.0001
127 MUSCULOSKELETAL DISCOMFORT 1 0.0001
128 TOOTHACHE 1 0.0001
129 CONJUNCTIVITIS 1 0.0001
130 THINKING ABNORMAL 1 0.0001
131 PROTEINURIA 1 0.0001
132 SLEEP APNOEA SYNDROME 1 0.0001
133 ACUTE RESPIRATORY FAILURE 1 0.0001
134 HERNIA 1 0.0001
135 EAR PAIN 1 0.0001
136 BONE PAIN 3 0.0001
137 DISABILITY 1 0.0001
138 HAEMATOCRIT DECREASED 1 0.0001
139 ILL-DEFINED DISORDER 3 0.0000
140 PERITONITIS 1 0.0000
141 EATING DISORDER 1 0.0000
142 FAECES DISCOLOURED 1 0.0000
143 STEVENS-JOHNSON SYNDROME 1 0.0000
144 TRANSAMINASES INCREASED 1 0.0000
145 COLITIS ULCERATIVE 2 0.0000
146 RASH PAPULAR 1 0.0000
147 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
148 INJECTION SITE URTICARIA 1 0.0000
149 DRY EYE 2 0.0000
150 PRODUCT COMPLAINT 1 0.0000
151 DIPLOPIA 1 0.0000
152 JOINT STIFFNESS 1 0.0000
153 ANHEDONIA 1 0.0000
154 FREQUENT BOWEL MOVEMENTS 1 0.0000
155 BLOOD BILIRUBIN INCREASED 1 0.0000
156 SKIN LESION 1 0.0000
157 WOUND 1 0.0000
158 EYE PAIN 2 0.0000
159 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
160 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
161 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
162 NASAL CONGESTION 2 0.0000
163 ASCITES 1 0.0000
164 LACRIMATION INCREASED 1 0.0000
165 FEELING HOT 2 0.0000
166 INJECTION SITE RASH 1 0.0000
167 SWELLING 3 0.0000
168 DRUG-INDUCED LIVER INJURY 1 0.0000
169 HEAD INJURY 1 0.0000
170 PRURITUS 12 0.0000
171 NIGHT SWEATS 1 0.0000
172 STAPHYLOCOCCAL INFECTION 1 0.0000
173 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
174 EXPIRED PRODUCT ADMINISTERED 1 0.0000
175 FUNGAL INFECTION 1 0.0000
176 EYE PRURITUS 1 0.0000
177 RASH MACULAR 1 0.0000
178 INJURY 2 0.0000
179 HYPOXIA 1 0.0000
180 LYMPHADENOPATHY 1 0.0000
181 RASH 12 0.0000
182 C-REACTIVE PROTEIN INCREASED 1 0.0000
183 RESPIRATORY FAILURE 2 0.0000
184 INFLUENZA 3 0.0000
185 EYE SWELLING 1 0.0000
186 INJECTION SITE SWELLING 2 0.0000
187 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
188 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
189 RHABDOMYOLYSIS 1 0.0000
190 ROAD TRAFFIC ACCIDENT 1 0.0000
191 HYPOACUSIS 1 0.0000
192 CONDITION AGGRAVATED 7 0.0000
193 SEPTIC SHOCK 1 0.0000
194 INJECTION SITE PAIN 7 0.0000
195 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
196 PULMONARY OEDEMA 1 0.0000
197 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
198 VISION BLURRED 3 0.0000
199 SKIN IRRITATION 1 0.0000
200 NEPHROLITHIASIS 1 0.0000
201 TINNITUS 1 0.0000
202 SKIN DISCOLOURATION 1 0.0000
203 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
204 OCULAR HYPERAEMIA 1 0.0000
205 COMA 1 0.0000
206 RASH ERYTHEMATOUS 1 0.0000
207 CONTUSION 2 0.0000
208 DRUG INTOLERANCE 2 0.0000
209 ILLNESS 2 0.0000
210 INFLAMMATION 1 0.0000
211 PANCREATITIS 1 0.0000
212 DEPRESSED MOOD 1 0.0000
213 DISTURBANCE IN ATTENTION 1 0.0000
214 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
215 CONSTIPATION 4 0.0000
216 HAEMATOCHEZIA 1 0.0000
217 BLISTER 1 0.0000
218 OXYGEN SATURATION DECREASED 1 0.0000
219 FLATULENCE 1 0.0000
220 LETHARGY 1 0.0000
221 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
222 VERTIGO 1 0.0000
223 RHINORRHOEA 1 0.0000
224 PRODUCT DOSE OMISSION 1 0.0000
225 BLOOD CREATININE INCREASED 1 0.0000
226 INJECTION SITE PRURITUS 1 0.0000
227 OFF LABEL USE 13 0.0000
228 HEPATIC ENZYME INCREASED 1 0.0000
229 BURNING SENSATION 1 0.0000
230 SLEEP DISORDER 1 0.0000
231 THERAPY INTERRUPTED 1 0.0000
232 SKIN BURNING SENSATION 1 0.0000
233 EPISTAXIS 1 0.0000
234 ACNE 1 0.0000
235 DIABETES MELLITUS 1 0.0000
236 ABDOMINAL PAIN 3 0.0000
237 CARDIAC FAILURE 1 0.0000
238 DRY MOUTH 1 0.0000
239 INFLUENZA LIKE ILLNESS 1 0.0000
240 CARDIAC ARREST 1 0.0000
241 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
242 RENAL IMPAIRMENT 1 0.0000
243 BALANCE DISORDER 1 0.0000
244 INTENTIONAL PRODUCT MISUSE 1 0.0000
245 MUSCULOSKELETAL STIFFNESS 1 0.0000
246 GASTROINTESTINAL DISORDER 1 0.0000
247 ADVERSE DRUG REACTION 1 0.0000
248 CARDIAC DISORDER 1 0.0000
249 PRODUCT USE ISSUE 2 0.0000
250 DYSPHAGIA 1 0.0000
251 PRODUCT DOSE OMISSION ISSUE 3 0.0000
252 ALOPECIA 2 0.0000
253 HEART RATE INCREASED 1 0.0000
254 SYNCOPE 1 0.0000
255 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
256 CHEST DISCOMFORT 1 0.0000
257 SINUSITIS 1 0.0000
258 ARTHRALGIA 4 0.0000
259 ABDOMINAL DISTENSION 1 0.0000
260 HYPERTENSION 2 0.0000
261 MUSCULAR WEAKNESS 1 0.0000
262 INCORRECT DOSE ADMINISTERED 2 0.0000
263 DECREASED APPETITE 2 0.0000
264 DISEASE PROGRESSION 1 0.0000
265 DRUG INEFFECTIVE 11 0.0000
266 JOINT SWELLING 1 0.0000
267 EMOTIONAL DISTRESS 1 0.0000
268 PAIN 5 0.0000
269 INJECTION SITE ERYTHEMA 1 0.0000
270 PSORIASIS 1 0.0000
271 MEMORY IMPAIRMENT 1 0.0000
272 WEIGHT DECREASED 2 0.0000
273 BLOOD PRESSURE INCREASED 1 0.0000
274 ACUTE KIDNEY INJURY 1 0.0000
275 PERIPHERAL SWELLING 1 0.0000
276 HEADACHE 4 0.0000
277 PARAESTHESIA 1 0.0000
278 DIARRHOEA 4 0.0000
279 CONFUSIONAL STATE 1 0.0000
280 URTICARIA 1 0.0000
281 ABDOMINAL DISCOMFORT 1 0.0000
282 TOXICITY TO VARIOUS AGENTS 1 0.0000
283 PYREXIA 2 0.0000
284 COVID-19 1 0.0000
285 MUSCLE SPASMS 1 0.0000
286 NASOPHARYNGITIS 1 0.0000
287 ASTHENIA 2 0.0000
288 ANAEMIA 1 0.0000
289 ERYTHEMA 1 0.0000
290 ABDOMINAL PAIN UPPER 1 0.0000
291 DEPRESSION 1 0.0000
292 BACK PAIN 1 0.0000
293 VOMITING 2 0.0000
294 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
295 DIZZINESS 2 0.0000
296 NAUSEA 3 0.0000
297 INSOMNIA 1 0.0000
298 COUGH 1 0.0000
299 ANXIETY 1 0.0000
300 PAIN IN EXTREMITY 1 0.0000
301 FATIGUE 1 0.0000